DYAI
Dyadic International, Inc.NASDAQHealthcare$0.89+1.50%ClosedMarket Cap: $32.5M
As of 2026-04-09
Valuation
P/E (TTM)
—
PEG
—
P/B
23.63
P/S
10.53
EV/EBITDA
-4.61
DCF Value
$-1.25
FCF Yield
-17.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
80.6%
Operating Margin
-231.2%
Net Margin
-238.3%
ROE
-695.8%
ROA
-74.0%
ROIC
-113.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $1.3M | 144.2% | $-1.5M | $-1.6M | $-0.04 | — |
| FY 2025 | $3.1M | 24.9% | $-7.1M | $-7.4M | $-0.23 | — |
| Q3 2025 | $1.2M | 78.1% | $-1.9M | $-2.0M | $-0.06 | — |
| Q2 2025 | $463.4K | -32.4% | $-1.7M | $-1.8M | $-0.06 | — |
| Q1 2025 | $183.1K | -62.6% | $-2.0M | $-2.0M | $-0.07 | — |
| Q4 2024 | $817.4K | 56.8% | $-1.5M | $-1.6M | $-0.05 | — |
| FY 2024 | $3.5M | 65.8% | $-5.9M | $-5.8M | $-0.20 | — |
| Q3 2024 | $2.0M | 79.8% | $-202.6K | $-203.5K | $-0.01 | — |
| Q2 2024 | $385.9K | 21.8% | $-2.0M | $-2.0M | $-0.07 | — |
| Q1 2024 | $334.6K | 57.0% | $-2.1M | $-2.0M | $-0.07 | — |
| Q4 2023 | $686.5K | 49.0% | $-2.2M | $-2.1M | $-0.07 | — |
| FY 2023 | $2.9M | 31.8% | $-8.2M | $-6.8M | $-0.24 | — |